Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TriMix vs Hyaluronic Acid in Dry Eye Disease
NCT06478134Phase 3Completed
- Sponsor
- University of Seville
- Start
- Jul 2023
- Primary completion
- Jan 2024
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 3 trial of Trimix in dry eye disease (DED), sponsored by University of Seville. Started Jul 2023; status: completed.
02
Drugs
Trimix
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT06478134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06478134.